Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10.9M
-
Number of holders
-
293
-
Total 13F shares, excl. options
-
9.77M
-
Shares change
-
-259K
-
Total reported value, excl. options
-
$2.05B
-
Value change
-
-$48.3M
-
Put/Call ratio
-
1.77
-
Number of buys
-
120
-
Number of sells
-
-151
-
Price
-
$209.43
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q4 2021
349 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q4 2021.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 293 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.77M shares
of 10.9M outstanding shares and own 89.54% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2M shares), VANGUARD GROUP INC (1.5M shares), RENAISSANCE TECHNOLOGIES LLC (798K shares), STATE STREET CORP (370K shares), DIMENSIONAL FUND ADVISORS LP (346K shares), RICE HALL JAMES & ASSOCIATES, LLC (327K shares), GEODE CAPITAL MANAGEMENT, LLC (229K shares), PRINCIPAL FINANCIAL GROUP INC (210K shares), PICTET ASSET MANAGEMENT SA (206K shares), and Bank of New York Mellon Corp (182K shares).
This table shows the top 293 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.